New threat to Pfizer-Allergan deal

ReutersNewsPublished: April 5, 201630 views
Published: April 5, 2016

The U.S. Treasury Department has taken steps to curb tax-avoiding corporate "inversions." As Hayley Platt reports, the pending $160 billion merger of Pfizer and Allergan is seen as a potential casualty.

Be the first to suggest a tag